Keystone eSymposia Logo

Synthetic Biology: At the Crossroads of Genetic Engineering and Human Therapeutics

May 3-4, 2021 | 10:00AM EDT | 2:00PM UTC | 4:00PM CEST*
*Program is in development and subject to change


  Register    Tweet This


 Attention


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.


 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries


Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.


Apply Here


Synthetic Biology tools and principles have matured tremendously over the last decade and have reached extraordinary levels of sophistication, both in eukaryotic and prokaryotic systems. Synthetic biology as a therapeutic modality is starting to enter multiple clinical studies and has the potential to have a significant impact on medicine across a wide range of diseases (e.g., metabolic, immune-mediated, cancer, and neurologic diseases). This Keystone Symposia conference will delve into the field of synthetic biology with a special emphasis on its applications to medicine. While there are conferences that capture synthetic biology in only a few talks mixed in among other various topics, there is a paucity of conferences focused on synthetic biology as drugs to treat disease. 

However, due to the rapid pace of fundamental scientific advances along with an expanding number of biotechnology companies and emerging clinical studies with synthetic biology at their core, this conference will be highly relevant for a wide audience of scientists both from academia and industry. In addition, other meetings in this field have a highly technology-driven focus on synthetic biology techniques with relatively little attention given to biological and medical context. Ultimately, this Keystone Symposia conference should inspire researchers from diverse backgrounds to discuss synthetic biology via many new angles.

Apply Here for Free On Demand Access

Pricing:

Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD

Deadlines:

Abstract Submission
‣ For Short Talk Consideration: March 22, 2021
‣ For Poster Booth: April 19, 2021
ePoster / SciTalk Submission: April 22, 2021
Financial Aid Application: April 19, 2021

*Abstract submission is required in order to submit an ePoster and/or Scitalk

#VKSSynthBio21


Financial Aid Opportunities

Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine-related fields, are eligible to apply for a FREE registration code.

Find out more about financial aid opportunities here!


Call For Abstracts

Showcase your work to global audiences on the eSymposia platform!

Submit your abstract for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program! See Abstract Deadline for Short Talk Consideration

ePoster presenters will be provided with their own dedicated page on the event website to display their work in multiple formats and interact with meeting participants. ePoster features include:

  • Abstract
  • Poster PDF for download
  • SciTalk – up to 5-minute video presentation, available on-demand
  • Live chat function to answer audience questions in real-time
  • Contact information for private follow-up discussion

To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.



Program Details



Keynote Speaker


Martin Fussenegger

Martin Fussenegger
ETH Zürich, Switzerland



Speaking at this eSymposia


Matthew Chang

National University of Singapore, Singapore


Yvonne Y. Chen

University of California, Los Angeles, USA


Virginia W. Cornish

Columbia University, USA


Luis Ángel Fernández

National Center of Biotechnology - CSIC, Spain


Martin Fussenegger

ETH Zürich, Switzerland


Roger Geiger

Institute for Research in Biomedicine, Switzerland


Jeff Hasty

University of California, San Diego, USA


David Hava

Synlogic, Inc., USA


Howard L. Kaufman

Massachusetts General Hospital, USA


Samira Kiani

University of Pittsburgh School of Medicine, USA


Gary K. Lee

Senti Biosciences, USA


Joshua N. Leonard

Northwestern University, USA


Cammie Lesser

Massachusetts General Hospital, USA


Jose M. Lora

enGene, Inc, USA


Timothy K. Lu

Massachusetts Institute of Technology, USA


Francisco J. Quintana

Harvard Medical School, USA


Owen J. L. Rackham

Duke-NUS, Singapore


Kole T. Roybal

University of California, San Francisco, USA


Zhen Xie

Tsinghua University, China




Sponsors


 

sponsor-carousel-cellpress.png

 




Additional Support



 

Sponsor-carousel-NIH-NIBIB.png

 

Funding for this conference was made possible (in part) by 1R13EB029305 - 01 from the National Institute of Biomedical Imaging and Bioengineering. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.




Media-in-Kind Support


sponsor-carousel-cellpress.png

sponsor-carousel-jcb-jem.png

sponsor-carousel-embo.png

sponsor-carousel-frontiers.png

Sponsor-Carousel-Leibert-Publishing.png

Sponsor-Carousel-nature-portfolio.png

 

sponsor-carousel-scientist.png

 





The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






#ScienceMustGoOn



This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community.  Here, Debbie Johnson, our CEO, explains how we're going to do that.




Donate to Keystone Symposia


Donate to Keystone Symposia



Tags: